GoodRx Holdings, Inc. (NASDAQ:GDRX) Q3 2023 Earnings Conference Call November 9, 2023 ET Company Participants Whitney Notaro - VP, IR Scott Wagner - Interim CEO Karsten Voermann - CFO Raj Beri - COO Conference Call Participants Charles Rhyee - Cowen Jailendra Singh - Truist Scott Schoenhaus - KeyBanc Lisa Gill - JPMorgan Eric Sheridan - Goldman Sachs Craig Hettenbach - Morgan Stanley Stan Berenshteyn - Wells Fargo Securities Daniel Grosslight - Citi Robert Simmons - D.A. Davidson Parker Snure - Raymond Jame ...

Scale our pharma manufacturer solutions efforts Scott Wagner Interim CEO Meaningful progress made against top priorities in Q3 1 2 3 4 Make sure we have the strongest network relationships and retail pharmacy strategy possible Hone our short- and medium-term growth plans for the core prescription transactions offering and align our teams and resources behind it November 9, 2023 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litig ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ________________________________ FORM 10-Q ________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Address of principal executive offices) (Zip Code) o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______. Commission File Number: 001-39549 _____________________ ...

GoodRx Holdings, Inc. (NASDAQ:GDRX) Q2 2023 Earnings Conference Call August 9, 2023 8:00 AM ET Company Participants Scott Wagner - Interim CEO Karsten Voermann - CFO Raj Beri - COO Whitney Notaro - VP, IR Conference Call Participants Charles Rhyee - TD Cowen Jonathan Yong - Credit Suisse Jailendra Singh - Truist Securities George Hill - Deutsche Bank Stan Berenshteyn - Wells Fargo Securities, LLC Sandy Draper - Guggenheim Securities, LLC Daniel Grosslight - Citigroup Jian Li - Evercore ISI McCoy Madson - Mo ...

Key Operating Metrics We exited the second quarter of 2023 with over 7 million prescription-related consumers that used GoodRx across our prescription transactions and subscription offerings. Our prescription-related consumers represent the sum of Monthly Active Consumers for the three months ended June 30, 2023 and subscribers to our subscription plans as of June 30, 2023. Each subscription plan may represent more than one subscriber since family subscription plans may include multiple members. Earnings Pr ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ________________________________ FORM 10-Q ________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______. Commission File Number: 001-39549 _________________________ ...

GoodRx Holdings, Inc. (NASDAQ:GDRX) Q1 2023 Earnings Conference Call May 10, 2023 8:00 AM ET Company Participants Aubrey Reynolds - Senior Manager Investor Relations Doug Hirsch - Chief Mission Officer Trevor Bezdek - Chairman Karsten Voermann - Chief Financial Officer Scott Wagner - Interim Chief Executive Officer Conference Call Participants Stephanie Davis - SVB Leerink Sandy Draper - Guggenheim Charles Rhyee - Cowen Jian Li - Evercore ISI Michael Cherny - Bank of America Stan Berenshteyn - Wells Fargo ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______. Commission File Number: 001-39549 GoodRx Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 47-5104396 (State or o ...

GoodRx Holdings, Inc. (NASDAQ:GDRX) Q4 2022 Earnings Conference Call February 28, 2023 5:00 PM ET Company Representatives Doug Hirsch - Co-Founders, Co-Chief Executive Officer Trevor Bezdek - Co-Founders, Co-Chief Executive Officer Karsten Voermann - Chief Financial Officer Aubrey Reynolds - Senior Investor Relations Manager Conference Call Participants Mark Mahaney - Evercore ISI Mitchell Kellett - Guggenheim Lucas Romanski - Cowen Michael Cherny - Bank of America Craig Hettenbach - Morgan Stanley Eric She ...

| --- | --- | --- | --- | |-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------- ...